Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

1.

The neglected co-star in the dementia drama: the putative roles of astrocytes in the pathogeneses of major neurocognitive disorders.

Jo WK, Law AC, Chung SK.

Mol Psychiatry. 2014 Feb;19(2):159-67. doi: 10.1038/mp.2013.171. Epub 2014 Jan 7. Review.

PMID:
24393807
[PubMed - indexed for MEDLINE]
2.

Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease.

Bell RD, Zlokovic BV.

Acta Neuropathol. 2009 Jul;118(1):103-13. doi: 10.1007/s00401-009-0522-3. Epub 2009 Mar 25. Review.

PMID:
19319544
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Alzheimer's disease.

De-Paula VJ, Radanovic M, Diniz BS, Forlenza OV.

Subcell Biochem. 2012;65:329-52. doi: 10.1007/978-94-007-5416-4_14. Review.

PMID:
23225010
[PubMed - indexed for MEDLINE]
4.

Differential deposition of amyloid beta peptides in cerebral amyloid angiopathy associated with Alzheimer's disease and vascular dementia.

Haglund M, Kalaria R, Slade JY, Englund E.

Acta Neuropathol. 2006 May;111(5):430-5. Epub 2006 Mar 23.

PMID:
16555084
[PubMed - indexed for MEDLINE]
5.

β-Amyloid, cholinergic transmission, and cerebrovascular system -- a developmental study in a mouse model of Alzheimer's disease.

Kuznetsova E, Schliebs R.

Curr Pharm Des. 2013;19(38):6749-65.

PMID:
23530514
[PubMed - indexed for MEDLINE]
6.

Astrocytes: implications for neuroinflammatory pathogenesis of Alzheimer's disease.

Li C, Zhao R, Gao K, Wei Z, Yin MY, Lau LT, Chui D, Hoi Yu AC.

Curr Alzheimer Res. 2011 Feb;8(1):67-80. Review.

PMID:
21143158
[PubMed - indexed for MEDLINE]
7.

The pericyte: a forgotten cell type with important implications for Alzheimer's disease?

Winkler EA, Sagare AP, Zlokovic BV.

Brain Pathol. 2014 Jul;24(4):371-86. doi: 10.1111/bpa.12152.

PMID:
24946075
[PubMed - in process]
8.

Vascular amyloid alters astrocytic water and potassium channels in mouse models and humans with Alzheimer's disease.

Wilcock DM, Vitek MP, Colton CA.

Neuroscience. 2009 Mar 31;159(3):1055-69. doi: 10.1016/j.neuroscience.2009.01.023. Epub 2009 Jan 19.

PMID:
19356689
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Alzheimer’s disease, cerebrovascular disease, and the β-amyloid cascade.

Honjo K, Black SE, Verhoeff NP.

Can J Neurol Sci. 2012 Nov;39(6):712-28. Review.

PMID:
23227576
[PubMed - indexed for MEDLINE]
10.

Contributions of brain insulin resistance and deficiency in amyloid-related neurodegeneration in Alzheimer's disease.

de la Monte SM.

Drugs. 2012 Jan 1;72(1):49-66. doi: 10.2165/11597760-000000000-00000. Review.

PMID:
22191795
[PubMed - indexed for MEDLINE]
11.

Multiple substrates of late-onset dementia: implications for brain protection.

Kalaria RN, Ballard CG, Ince PG, Kenny RA, McKeith IG, Morris CM, O'Brien JT, Perry EK, Perry RH, Edwardson JA.

Novartis Found Symp. 2001;235:49-60; discussion 60-5. Review.

PMID:
11280033
[PubMed - indexed for MEDLINE]
12.

Cerebrovascular damage as a cause for Alzheimer's disease.

Humpel C, Marksteiner J.

Curr Neurovasc Res. 2005 Oct;2(4):341-7. Review.

PMID:
16181125
[PubMed - indexed for MEDLINE]
13.

New therapeutic targets in the neurovascular pathway in Alzheimer's disease.

Zlokovic BV.

Neurotherapeutics. 2008 Jul;5(3):409-14. doi: 10.1016/j.nurt.2008.05.011. Review.

PMID:
18625452
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Cerebrovascular disease and the pathophysiology of Alzheimer's disease. Implications for therapy.

Weller RO, Cohen NR, Nicoll JA.

Panminerva Med. 2004 Dec;46(4):239-51. Review.

PMID:
15876980
[PubMed - indexed for MEDLINE]
15.

Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.

Chen Z, Zhong C.

Prog Neurobiol. 2013 Sep;108:21-43. doi: 10.1016/j.pneurobio.2013.06.004. Epub 2013 Jul 11. Review.

PMID:
23850509
[PubMed - indexed for MEDLINE]
Free Article
16.

Unifying concept for Alzheimer's disease, vascular dementia and normal pressure hydrocephalus - a hypothesis.

Chakravarty A.

Med Hypotheses. 2004;63(5):827-33.

PMID:
15488655
[PubMed - indexed for MEDLINE]
17.

Synergistic memory impairment through the interaction of chronic cerebral hypoperfusion and amlyloid toxicity in a rat model.

Choi BR, Lee SR, Han JS, Woo SK, Kim KM, Choi DH, Kwon KJ, Han SH, Shin CY, Lee J, Chung CS, Lee SR, Kim HY.

Stroke. 2011 Sep;42(9):2595-604. doi: 10.1161/STROKEAHA.111.620179. Epub 2011 Jul 7.

PMID:
21737797
[PubMed - indexed for MEDLINE]
Free Article
18.

Endothelin receptor antagonists: potential in Alzheimer's disease.

Palmer J, Love S.

Pharmacol Res. 2011 Jun;63(6):525-31. doi: 10.1016/j.phrs.2010.12.008. Epub 2010 Dec 27. Review.

PMID:
21193044
[PubMed - indexed for MEDLINE]
19.

Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease.

Jack CR Jr, Wiste HJ, Vemuri P, Weigand SD, Senjem ML, Zeng G, Bernstein MA, Gunter JL, Pankratz VS, Aisen PS, Weiner MW, Petersen RC, Shaw LM, Trojanowski JQ, Knopman DS; Alzheimer's Disease Neuroimaging Initiative.

Brain. 2010 Nov;133(11):3336-48. doi: 10.1093/brain/awq277. Epub 2010 Oct 8.

PMID:
20935035
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Cerebral ischemia aggravates cognitive impairment in a rat model of Alzheimer's disease.

Li J, Wang YJ, Zhang M, Fang CQ, Zhou HD.

Life Sci. 2011 Jul 18;89(3-4):86-92. doi: 10.1016/j.lfs.2011.04.024. Epub 2011 May 18.

PMID:
21620868
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk